i Next Innovation SRL
4.1 FTEi Next Innovation reported total assets of 879,845 € at the end of the 2025 financial year (annual accounts filed with the NBB on 27 Jul 2026), with 4.1 full-time equivalents.
The score of i Next Innovation shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -9 % Total assets +24 % Headcount (avg FTE) -45 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
i Next Innovation's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 53,313 € | ||||
| Equity | 312,075 € | ||||
| Cash | 17,606 € | ||||
| EBITDA | 216,844 € | ||||
| Total assets | 879,845 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 27 Jul 2026
- Year ended 31 Dec 2024filed on 20 Jun 2025
- Year ended 31 Dec 2023filed on 19 Aug 2024
- Year ended 31 Dec 2022filed on 25 Aug 2023
- Year ended 31 Dec 2021filed on 30 Aug 2022
i Next Innovation's financial analysis
- Solvency35.5%sector median: 46.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of i Next Innovation
i Next Innovation's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0898.612.255
- VAT number
- BE0898612255
- Peppol
- Registered · 0208:0898612255 · as of 11 Nov 2026
- Legal form
- SRL
- Incorporated
- 17 Jun 2008
- Registered office
- 1325 Chaumont-Gistoux
- Size
- Micro · 4.1 FTE
- Latest accounts
- 2025 · filed on 27 Jul 2026
- Activity
- Retail sale of medical and orthopaedic goods, except corrective glasses, lenses and sunglasses (NACE 47741)
i Next Innovation (SRL) has been based in Chaumont-Gistoux since 2008, active in: retail sale of medical and orthopaedic goods, except corrective glasses, lenses and sunglasses. For 2025, it reports a net profit of 53,313 € and equity of 312,075 €; its revenue is not published. With 4.1 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 35.5%, below the median of its sector (46.8%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to i Next Innovation
Companies in the same business, of comparable size and area, outside its group.
- BOP mon artisan Manufacture of medical and dental instruments and supplies Ciney · balance sheet 718,041 €
- Gestec Orthopédie Manufacture of medical and dental instruments and supplies Namur · balance sheet €1.57m
- Evision Care Retail sale of medical and orthopaedic goods Ronse · balance sheet €1.25m
- Acousti'conseil Retail sale of medical and orthopaedic goods Flémalle · balance sheet €1.17m
- Dental Sud Retail sale of medical and orthopaedic goods Namur · balance sheet 34,848 €
- Sobry Ortho Projects Retail sale of medical and orthopaedic goods Sint-Martens-Latem · balance sheet 413,443 €
- New Davigo Retail sale of medical and orthopaedic goods Forest · balance sheet 933,610 €
- 2enjoy Retail sale of medical and orthopaedic goods Oudenaarde · balance sheet 298 €
Frequently asked questions about i Next Innovation
What is the revenue of i Next Innovation?
i Next Innovation files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of i Next Innovation?
In Belgium, the VAT number is the company number prefixed with BE: BE0898612255 for i Next Innovation, if the company is VAT-registered. Its company number (CBE) is 0898.612.255.
Where is the registered office of i Next Innovation?
According to the CBE register, the registered office of i Next Innovation is in 1325 Chaumont-Gistoux.
What is the equity of i Next Innovation?
At the close of the 2025 financial year, the equity of i Next Innovation amounts to 312,075 €, a solvency of 35.5% of total assets.
How many people work at i Next Innovation?
4.1 full-time equivalents on average according to the 2025 social balance sheet.
Who manages i Next Innovation?
The register lists 2 active mandates at i Next Innovation. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of i Next Innovation
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →